Dietary polyphenol intake and risk of hypertension in the Polish arm of the HAPIEE study

European Journal of Nutrition

Volumn 57, Issue 4, 2018, Pages 1535-1544

  Grosso, Giuseppe ^a,b   Stepaniak, Urszula ^b   Micek, Agnieszka ^b   Kozela, Magdalena ^b   Stefler, Denes ^c   Bobak, Martin ^c   Pajak, Andrzej ^b  

^a Integrated Cancer Registry of Catania Messina Siracusa Enna ^*  (Italy)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Dietary polyphenols; Flavanols; Flavonoids; Hypertension; Phenolic acids

Indexed keywords

ACID; ANTHOCYANIN; COUMARIC ACID; DIHYDROCHALCONE; FLAVANOL DERIVATIVE; FLAVANONE DERIVATIVE; FLAVONE DERIVATIVE; HYDROXYBENZOIC ACID DERIVATIVE; ISOFLAVONE DERIVATIVE; PHENOL DERIVATIVE; POLYPHENOL DERIVATIVE; UNCLASSIFIED DRUG; POLYPHENOL;

ADULT; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; DIETARY INTAKE; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NUTRITIONAL ASSESSMENT; POLISH CITIZEN; SEX DIFFERENCE; AGED; DIET; POLAND; PROSPECTIVE STUDY;

AGED; DIET; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POLAND; POLYPHENOLS; PROSPECTIVE STUDIES;

EID: 85018756214     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-017-1438-7     Document Type: Article

References (56)

1. D’Archivio M, Filesi C, Di Benedetto R, Gargiulo R, Giovannini C, Masella R (2007) Polyphenols, dietary sources and bioavailability. Ann Ist Super Sanita 43(4):348–361
2. Landete JM (2012) Updated knowledge about polyphenols: functions, bioavailability, metabolism, and health. Crit Rev Food Sci Nutr 52(10):936–948. doi:10.1080/10408398.2010.513779
3. Manach C, Williamson G, Morand C, Scalbert A, Remesy C (2005) Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81(1 Suppl):230S–242S
4. Dwyer JT, Peterson JJ (2002) Measuring flavonoid intake: need for advanced tools. Public Health Nutr 5(6A):925–930. doi:10.1079/PHN2002373
5. Stedile N, Canuto R, de Col CD, de Sene JS, Stolfo A, Wisintainer GN, Henriques JA, Salvador M (2016) Dietary total antioxidant capacity is associated with plasmatic antioxidant capacity, nutrient intake and lipid and DNA damage in healthy women. Int J Food Sci Nutr 67(4):479–488. doi:10.3109/09637486.2016.1164670
6. Goya L, Martin MA, Sarria B, Ramos S, Mateos R, Bravo L (2016) Effect of cocoa and its flavonoids on biomarkers of inflammation: studies of cell culture, animals and humans. Nutrients 8(4):212. doi:10.3390/nu8040212
7. Cassidy A, O’Reilly EJ, Kay C, Sampson L, Franz M, Forman JP, Curhan G, Rimm EB (2011) Habitual intake of flavonoid subclasses and incident hypertension in adults. Am J Clin Nutr 93(2):338–347. doi:10.3945/ajcn.110.006783
8. Goodman-Gruen D, Kritz-Silverstein D (2001) Usual dietary isoflavone intake is associated with cardiovascular disease risk factors in postmenopausal women. J Nutr 131(4):1202–1206
9. Knekt P, Kumpulainen J, Jarvinen R, Rissanen H, Heliovaara M, Reunanen A, Hakulinen T, Aromaa A (2002) Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 76(3):560–568
10. Lajous M, Rossignol E, Fagherazzi G, Perquier F, Scalbert A, Clavel-Chapelon F, Boutron-Ruault MC (2016) Flavonoid intake and incident hypertension in women. Am J Clin Nutr 103(4):1091–1098. doi:10.3945/ajcn.115.109249
11. de Kleijn MJ, van der Schouw YT, Wilson PW, Grobbee DE, Jacques PF (2002) Dietary intake of phytoestrogens is associated with a favorable metabolic cardiovascular risk profile in postmenopausal U.S.women: the Framingham study. J Nutr 132(2):276–282
12. van der Schouw YT, Sampson L, Willett WC, Rimm EB (2005) The usual intake of lignans but not that of isoflavones may be related to cardiovascular risk factors in U.S. men. J Nutr 135(2):260–266
13. Sohrab G, Hosseinpour-Niazi S, Hejazi J, Yuzbashian E, Mirmiran P, Azizi F (2013) Dietary polyphenols and metabolic syndrome among Iranian adults. Int J Food Sci Nutr 64(6):661–667. doi:10.3109/09637486.2013.787397
14. Tresserra-Rimbau A, Rimm EB, Medina-Remon A, Martinez-Gonzalez MA, de la Torre R, Corella D, Salas-Salvado J, Gomez-Gracia E, Lapetra J, Aros F, Fiol M, Ros E, Serra-Majem L, Pinto X, Saez GT, Basora J, Sorli JV, Martinez JA, Vinyoles E, Ruiz-Gutierrez V, Estruch R, Lamuela-Raventos RM, Investigators PS (2014) Inverse association between habitual polyphenol intake and incidence of cardiovascular events in the PREDIMED study. Nutr Metab Cardiovasc Dis 24(6):639–647. doi:10.1016/j.numecd.2013.12.014
15. Peasey A, Bobak M, Kubinova R, Malyutina S, Pajak A, Tamosiunas A, Pikhart H, Nicholson A, Marmot M (2006) Determinants of cardiovascular disease and other non-communicable diseases in Central and Eastern Europe: rationale and design of the HAPIEE study. BMC Public Health 6:255. doi:10.1186/1471-2458-6-255
16. Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, Hennekens CH, Speizer FE (1985) Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 122(1):51–65
17. Brunner E, Stallone D, Juneja M, Bingham S, Marmot M (2001) Dietary assessment in Whitehall II: comparison of 7 d diet diary and food-frequency questionnaire and validity against biomarkers. Br J Nutr 86(3):405–414
18. Phenol-Explorer: an online comprehensive database on polyphenol contents in foods. (2010). http://www.phenol-explorer.eu. Accessed Aug 2016
19. Grosso G, Stepaniak U, Topor-Madry R, Szafraniec K, Pajak A (2014) Estimated dietary intake and major food sources of polyphenols in the Polish arm of the HAPIEE study. Nutrition 30(11–12):1398–1403. doi:10.1016/j.nut.2014.04.012
20. Buscemi S, Sprini D, Grosso G, Galvano F, Nicolucci A, Lucisano G, Massenti FM, Amodio E, Rini GB (2014) Impact of lifestyle on metabolic syndrome in apparently healthy people. Eat Weight Disord 19(2):225–232. doi:10.1007/s40519-014-0117-4
21. Grosso G, Stepaniak U, Micek A, Stefler D, Bobak M, Pajak A (2016) Dietary polyphenols are inversely associated with metabolic syndrome in Polish adults of the HAPIEE study. Eur J Nutr. doi:10.1007/s00394-016-1187-z
22. Medina-Remon A, Zamora-Ros R, Rotches-Ribalta M, Andres-Lacueva C, Martinez-Gonzalez MA, Covas MI, Corella D, Salas-Salvado J, Gomez-Gracia E, Ruiz-Gutierrez V, Garcia de la Corte FJ, Fiol M, Pena MA, Saez GT, Ros E, Serra-Majem L, Pinto X, Warnberg J, Estruch R, Lamuela-Raventos RM, Investigators PS (2011) Total polyphenol excretion and blood pressure in subjects at high cardiovascular risk. Nutr Metab Cardiovasc Dis 21(5):323–331. doi:10.1016/j.numecd.2009.10.019
23. Medina-Remon A, Tresserra-Rimbau A, Pons A, Tur JA, Martorell M, Ros E, Buil-Cosiales P, Sacanella E, Covas MI, Corella D, Salas-Salvado J, Gomez-Gracia E, Ruiz-Gutierrez V, Ortega-Calvo M, Garcia-Valdueza M, Aros F, Saez GT, Serra-Majem L, Pinto X, Vinyoles E, Estruch R, Lamuela-Raventos RM, Investigators PS (2015) Effects of total dietary polyphenols on plasma nitric oxide and blood pressure in a high cardiovascular risk cohort. The PREDIMED randomized trial. Nutr Metab Cardiovasc Dis 25(1):60–67. doi:10.1016/j.numecd.2014.09.001
24. Vitaglione P, Donnarumma G, Napolitano A, Galvano F, Gallo A, Scalfi L, Fogliano V (2007) Protocatechuic acid is the major human metabolite of cyanidin-glucosides. J Nutr 137(9):2043–2048
25. Liu XX, Li SH, Chen JZ, Sun K, Wang XJ, Wang XG, Hui RT (2012) Effect of soy isoflavones on blood pressure: a meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis 22(6):463–470. doi:10.1016/j.numecd.2010.09.006
26. Kay CD, Hooper L, Kroon PA, Rimm EB, Cassidy A (2012) Relative impact of flavonoid composition, dose and structure on vascular function: a systematic review of randomised controlled trials of flavonoid-rich food products. Mol Nutr Food Res 56(11):1605–1616. doi:10.1002/mnfr.201200363
27. Desch S, Schmidt J, Kobler D, Sonnabend M, Eitel I, Sareban M, Rahimi K, Schuler G, Thiele H (2010) Effect of cocoa products on blood pressure: systematic review and meta-analysis. Am J Hypertens 23(1):97–103. doi:10.1038/ajh.2009.213
28. Zhu Y, Bo Y, Wang X, Lu W, Wang X, Han Z, Qiu C (2016) The effect of anthocyanins on blood pressure: a PRISMA-compliant meta-analysis of randomized clinical trials. Medicine 95(15):e3380. doi:10.1097/MD.0000000000003380
29. Kent K, Charlton KE, Jenner A, Roodenrys S (2016) Acute reduction in blood pressure following consumption of anthocyanin-rich cherry juice may be dose-interval dependant: a pilot cross-over study. Int J Food Sci Nutr 67(1):47–52. doi:10.3109/09637486.2015.1121472
30. Grosso G, Stepaniak U, Micek A, Topor-Madry R, Stefler D, Szafraniec K, Bobak M, Pajak A (2015) A Mediterranean-type diet is associated with better metabolic profile in urban Polish adults: results from the HAPIEE study. Metabolism 64(6):738–746. doi:10.1016/j.metabol.2015.02.007
31. Stefler D, Pikhart H, Jankovic N, Kubinova R, Pajak A, Malyutina S, Simonova G, Feskens EJ, Peasey A, Bobak M (2014) Healthy diet indicator and mortality in Eastern European populations: prospective evidence from the HAPIEE cohort. Eur J Clin Nutr 68(12):1346–1352. doi:10.1038/ejcn.2014.134
32. Stepaniak U, Micek A, Grosso G, Stefler D, Topor-Madry R, Kubinova R, Malyutina S, Peasey A, Pikhart H, Nikitin Y, Bobak M, Pajak A (2016) Antioxidant vitamin intake and mortality in three Central and Eastern European urban populations: the HAPIEE study. Eur J Nutr 55(2):547–560. doi:10.1007/s00394-015-0871-8
33. Peluso I, Raguzzini A, Serafini M (2013) Effect of flavonoids on circulating levels of TNF-alpha and IL-6 in humans: a systematic review and meta-analysis. Mol Nutr Food Res 57(5):784–801. doi:10.1002/mnfr.201200721
34. Steffen Y, Gruber C, Schewe T, Sies H (2008) Mono-O-methylated flavanols and other flavonoids as inhibitors of endothelial NADPH oxidase. Arch Biochem Biophys 469(2):209–219. doi:10.1016/j.abb.2007.10.012
35. Steffen Y, Schewe T, Sies H (2007) (-)-Epicatechin elevates nitric oxide in endothelial cells via inhibition of NADPH oxidase. Biochem Biophys Res Commun 359(3):828–833. doi:10.1016/j.bbrc.2007.05.200
36. Loke WM, Hodgson JM, Proudfoot JM, McKinley AJ, Puddey IB, Croft KD (2008) Pure dietary flavonoids quercetin and (-)-epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy men. Am J Clin Nutr 88(4):1018–1025
37. Schnorr O, Brossette T, Momma TY, Kleinbongard P, Keen CL, Schroeter H, Sies H (2008) Cocoa flavanols lower vascular arginase activity in human endothelial cells in vitro and in erythrocytes in vivo. Arch Biochem Biophys 476(2):211–215. doi:10.1016/j.abb.2008.02.040
38. Actis-Goretta L, Ottaviani JI, Fraga CG (2006) Inhibition of angiotensin converting enzyme activity by flavanol-rich foods. J Agric Food Chem 54(1):229–234. doi:10.1021/jf052263o
39. Marventano S, Kolacz P, Castellano S, Galvano F, Buscemi S, Mistretta A, Grosso G (2015) A review of recent evidence in human studies of n-3 and n-6 PUFA intake on cardiovascular disease, cancer, and depressive disorders: does the ratio really matter? Int J Food Sci Nutr 66(6):611–622. doi:10.3109/09637486.2015.1077790
40. Onakpoya IJ, Spencer EA, Thompson MJ, Heneghan CJ (2015) The effect of chlorogenic acid on blood pressure: a systematic review and meta-analysis of randomized clinical trials. J Hum Hypertens 29(2):77–81. doi:10.1038/jhh.2014.46
41. Steffen M, Kuhle C, Hensrud D, Erwin PJ, Murad MH (2012) The effect of coffee consumption on blood pressure and the development of hypertension: a systematic review and meta-analysis. J Hypertens 30(12):2245–2254. doi:10.1097/HJH.0b013e3283588d73
42. Marventano S, Salomone F, Godos J, Pluchinotta F, Del Rio D, Mistretta A, Grosso G (2016) Coffee and tea consumption in relation with non-alcoholic fatty liver and metabolic syndrome: a systematic review and meta-analysis of observational studies. Clin Nutr. doi:10.1016/j.clnu.2016.03.012
43. Grosso G, Stepaniak U, Micek A, Topor-Madry R, Pikhart H, Szafraniec K, Pajak A (2015) Association of daily coffee and tea consumption and metabolic syndrome: results from the Polish arm of the HAPIEE study. Eur J Nutr 54(7):1129–1137. doi:10.1007/s00394-014-0789-6
44. Grosso G, Galvano F (2016) Mediterranean diet adherence in children and adolescents in southern European countries. NFS J 3:13–19. doi:10.1016/j.nfs.2016.02.004
45. Godos J, Pluchinotta FR, Marventano S, Buscemi S, Li Volti G, Galvano F, Grosso G (2014) Coffee components and cardiovascular risk: beneficial and detrimental effects. Int J Food Sci Nutr 65(8):925–936. doi:10.3109/09637486.2014.940287
46. Zhao Y, Wang J, Ballevre O, Luo H, Zhang W (2012) Antihypertensive effects and mechanisms of chlorogenic acids. Hypertens Res 35(4):370–374. doi:10.1038/hr.2011.195
47. Ochiai R, Sugiura Y, Otsuka K, Katsuragi Y, Hashiguchi T (2015) Coffee bean polyphenols ameliorate postprandial endothelial dysfunction in healthy male adults. Int J Food Sci Nutr 66(3):350–354. doi:10.3109/09637486.2015.1007453
48. Gencoglu H, Tuzcu M, Hayirli A, Sahin K (2015) Protective effects of resveratrol against streptozotocin-induced diabetes in rats by modulation of visfatin/sirtuin-1 pathway and glucose transporters. Int J Food Sci Nutr 66(3):314–320. doi:10.3109/09637486.2014.1003534
49. Riccioni G, Gammone MA, Tettamanti G, Bergante S, Pluchinotta FR, D’Orazio N (2015) Resveratrol and anti-atherogenic effects. Int J Food Sci Nutr 66(6):603–610. doi:10.3109/09637486.2015.1077796
50. Liu Y, Ma W, Zhang P, He S, Huang D (2015) Effect of resveratrol on blood pressure: a meta-analysis of randomized controlled trials. Clin Nutr 34(1):27–34. doi:10.1016/j.clnu.2014.03.009
51. Semba RD, Ferrucci L, Bartali B, Urpi-Sarda M, Zamora-Ros R, Sun K, Cherubini A, Bandinelli S, Andres-Lacueva C (2014) Resveratrol levels and all-cause mortality in older community-dwelling adults. JAMA Intern Med 174(7):1077–1084. doi:10.1001/jamainternmed.2014.1582
52. Tome-Carneiro J, Larrosa M, Gonzalez-Sarrias A, Tomas-Barberan FA, Garcia-Conesa MT, Espin JC (2013) Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence. Curr Pharm Des 19(34):6064–6093
53. Fistonic I, Situm M, Bulat V, Harapin M, Fistonic N, Verbanac D (2012) Olive oil biophenols and women’s health. Med Glas (Zenica) 9(1):1–9
54. Waterman E, Lockwood B (2007) Active components and clinical applications of olive oil. Altern Med Rev 12(4):331–342
55. Arranz S, Chiva-Blanch G, Valderas-Martinez P, Medina-Remon A, Lamuela-Raventos RM, Estruch R (2012) Wine, beer, alcohol and polyphenols on cardiovascular disease and cancer. Nutrients 4(7):759–781. doi:10.3390/nu4070759
56. Chiva-Blanch G, Arranz S, Lamuela-Raventos RM, Estruch R (2013) Effects of wine, alcohol and polyphenols on cardiovascular disease risk factors: evidences from human studies. Alcohol Alcohol 48(3):270–277. doi:10.1093/alcalc/agt007